Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. (AXSM) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 120 transactions totaling $91.2M, demonstrating a bearish sentiment with -$88.0M in net insider flow. The most recent transaction on Feb 20, 2026 involved a transaction of 12,485 shares valued at $0.
AXSM Insider Activity Summary
Who Is Buying AXSM Stock?
No significant insider buying has been recorded for AXSM in the recent period.
Who Is Selling AXSM Stock?
No significant insider selling has been recorded for AXSM in the recent period.
Is Axsome Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AXSM is bearish with an Insider Alignment Score of 2/100 and a net flow of -$88.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AXSM Frequently Asked Questions
Understanding AXSM Insider Activity
Insider trading at Axsome Therapeutics, Inc. (AXSM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading AXSM stock, having executed 120 transactions in the past 90 days. The most active insider is Herriot Tabuteau (Executive), who has made 28 transactions totaling $55.4M.
Related Tools
Track Axsome Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AXSM file new Form 4 transactions